YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression
Gao, YJ; Zhang, WJ; Han, XK; Li, FM; Wang, XJ; Wang, R; Fang, ZY; Tong, XY; Yao, S; Li, F
刊名NATURE COMMUNICATIONS
2014
卷号5期号:1页码:4629-4629
通讯作者Zhang, L (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China.,RayZhang@sibcb.ac.cn
英文摘要Whether the Hippo pathway contributes to cell lineage transition under pathological conditions, especially tumorigenesis, remains largely unknown. Here we show that YAP, the major effector of the Hippo pathway, displays a distinct activation pattern in lung adenocarcinoma (ADC) and squamous cell carcinoma (SCC); YAP is initially activated by LKB1 loss in lung ADC, which upregulates ZEB2 expression and represses DNp63 transcription in a default manner. During transdifferentiation, YAP is inactivated, which in turn relieves ZEB2-mediated default repression of DNp63 and triggers squamous differentiation reprogramming. Disruption of the YAP barrier for phenotypic transition significantly accelerates squamous transdifferentiation, whereas constitutive YAP activation conversely inhibits this transition. More importantly, ectopic DNp63 expression rescues the inhibitory effect of YAP on squamous transdifferentiation. These findings have established YAP as an essential barrier for lung cancer cell fate conversion and provided a mechanism for regulating cancer plasticity, which might hold important implication for YAP-targeted therapies.
学科主题Science & Technology - Other Topics
类目[WOS]Multidisciplinary Sciences
关键词[WOS]YES-ASSOCIATED PROTEIN ; TUMOR-SUPPRESSOR PATHWAY ; STEM-LIKE CELLS ; HIPPO PATHWAY ; ADENOSQUAMOUS CARCINOMA ; HEPATOCELLULAR-CARCINOMA ; SIZE-CONTROL ; ORGAN SIZE ; CANCER ; DIFFERENTIATION
收录类别SCI
语种英语
WOS记录号WOS:000341057000020
内容类型期刊论文
版本出版稿
源URL[http://202.127.25.143/handle/331003/284]  
专题上海生化细胞研究所_上海生科院生化细胞研究所
推荐引用方式
GB/T 7714
Gao, YJ,Zhang, WJ,Han, XK,et al. YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression[J]. NATURE COMMUNICATIONS,2014,5(1):4629-4629.
APA Gao, YJ.,Zhang, WJ.,Han, XK.,Li, FM.,Wang, XJ.,...&Ji, HB.(2014).YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression.NATURE COMMUNICATIONS,5(1),4629-4629.
MLA Gao, YJ,et al."YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression".NATURE COMMUNICATIONS 5.1(2014):4629-4629.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace